ArticleScientific reports2024

LncRNA LYPLAL1, miR-204-5p, and SIRT1: novel signatures for risk assessment of diabetic macrovascular complications.

Maysa A Mobasher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.